Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study

被引：7

作者：

Soto, Caitlin L. ^{[1
]}

Hsu, Alice J. ^{[1
]}

Lee, Jae Hyoung ^{[2
]}

Dzintars, Kathryn ^{[1
]}

Choudhury, Rebecca ^{[3
]}

Jenkins, Timothy C. ^{[4
]}

Mccreary, Erin K. ^{[5
]}

Quartuccio, Katelyn S. ^{[6
]}

Stohs, Erica J. ^{[7
]}

Zimmerman, Matty ^{[1
]}

Tamma, Pranita D. ^{[2
,8
]}

机构：

[1] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD USA

[2] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21287 USA

[3] Montefiore Med Ctr, Dept Med, Bronx, NY USA

[4] Denver Hlth, Dept Med, Denver, CO USA

[5] Univ Pittsburgh, Dept Med, Sch Med, Pittsburgh, PA USA

[6] Univ Rochester, Med Ctr, Dept Pharm, Rochester, NY 14627 USA

[7] Univ Nebraska, Dept Med, Med Ctr, Omaha, NE USA

[8] Johns Hopkins Univ, Dept Pediat, Sch Med, 200 North Wolfe St,Rubinstein Bldg,Rm 3149, Baltimore, MD 21287 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2024年 / 78卷 / 01期

关键词：

carbapenem-resistant Enterobacterales; bacteremia; ceftazidime-avibactam; meropenem-vaborbactam;

D O I：

10.1093/cid/ciad476

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In a propensity-score-weighted cohort of 183 adults with carbapenem-resistant Enterobacterales bacteremia at 24 US hospitals, patients receiving short courses of active therapy (7-10 days, median 9 days) experienced similar odds of recurrent bacteremia or death within 30 days as those receiving prolonged courses of active therapy (14-21 days, median 14 days).

引用

页码：27 / 30

页数：4

共 50 条

[21] Mortality and clinical outcomes of ceftazidime/avibactam vs best available therapy in treating carbapenem-resistant enterobacterales infections: A retrospective cohort study [J].

Alhamed, Nada ;

Hashhoush, Mai ;

Al-Omari, Raghad ;

Alomani, Marwa ;

Alomar, Reem S. .

CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2025, 34

[22] Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data [J].

Clancy, Cornelius J. ;

Potoski, Brian A. ;

Buehrle, Deanna ;

Nguyen, M. Hong .

OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (08)

[23] High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections A retrospective cohort study [J].

Geng, Ting-Ting ;

Xu, Xin ;

Huang, Man .

MEDICINE, 2018, 97 (08)

[24] Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections [J].

King, Madeline ;

Heil, Emily ;

Kuriakose, Safia ;

Bias, Tiffany ;

Huang, Vanthida ;

El-Beyrouty, Claudine ;

McCoy, Dorothy ;

Hiles, Jon ;

Richards, Lynette ;

Gardner, Julianne ;

Harrington, Nicole ;

Biason, Kenneth ;

Gallagher, Jason C. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (07)

[25] Risk factors of Carbapenem-resistant Enterobacterales intestinal colonization for subsequent infections in hematological patients: a retrospective case-control study [J].

Wang, Zihan ;

Shao, Chunhong ;

Shao, Jing ;

Hao, Yingying ;

Jin, Yan .

FRONTIERS IN MICROBIOLOGY, 2024, 15

[26] Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases [J].

Zhen, Sisi ;

Zhao, Yuanqi ;

Chen, Zhangjie ;

Zhang, Tingting ;

Wang, Jieru ;

Jiang, Erlie ;

Zhang, Fengkui ;

Mi, Yingchang ;

Zhu, Xiaofan ;

Han, Mingzhe ;

Xiao, Zhijian ;

Wang, Jianxiang ;

Feng, Sizhou .

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13

[27] A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections [J].

Luterbach, Courtney L. ;

Qiu, Hongqiang ;

Hanafin, Patrick O. ;

Sharma, Rajnikant ;

Piscitelli, Joseph ;

Lin, Feng-Chang ;

Ilomaki, Jenni ;

Cober, Eric ;

Salata, Robert A. ;

Kalayjian, Robert C. ;

Watkins, Richard R. ;

Doi, Yohei ;

Kaye, Keith S. ;

Nation, Roger L. ;

Bonomo, Robert A. ;

Landersdorfer, Cornelia B. ;

van Duin, David ;

Rao, Gauri G. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (10)

[28] Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa [J].

Alosaimy, Sara ;

Lagnf, Abdalhamid M. ;

Morrisette, Taylor ;

Scipione, Marco R. ;

Zhao, Jing J. ;

Jorgensen, Sarah C. J. ;

Mynatt, Ryan ;

Carlson, Travis J. ;

Jo, Jinhee ;

Garey, Kevin W. ;

Allen, David ;

DeRonde, Kailynn ;

Vega, Ana D. ;

Abbo, Lilian M. ;

Venugopalan, Veena ;

Athans, Vasilios ;

Saw, Stephen ;

Claeys, Kimberly C. ;

Miller, Mathew ;

Molina, Kyle C. ;

Veve, Michael ;

Kufel, Wesley D. ;

Amaya, Lee ;

Yost, Christine ;

Ortwine, Jessica ;

Davis, Susan L. ;

Rybak, Michael J. .

OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (08)

[29] Impact of Antibiotic Therapy with Ceftazidime Avibactam vs. Best Available Therapy in Adult Patients with Bacteremia Caused by Carbapenem-Resistant Enterobacterales [J].

Arboleda, Daniel ;

Buitrago, Camilo ;

Vergara, Erika Paola ;

Nocua-Baez, Laura Cristina ;

Saavedra, Carlos Humberto ;

Cortes, Jorge Alberto .

ANTIBIOTICS-BASEL, 2025, 14 (03)

[30] A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting [J].

Aslan, Abdullah Tarik ;

Kirbas, Ekin ;

Sancak, Banu ;

Tanriverdi, Elif Seren ;

Otlu, Baris ;

Gursoy, Nafia Canan ;

Yilmaz, Yakut Akyon ;

Tozluyurt, Abdullah ;

Liste, Umran ;

Bicakcigil, Asiye ;

Hazirolan, Gulsen ;

Dag, Osman ;

Guven, Gulay Sain ;

Akova, Murat .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (04)

← 1 2 3 4 5 →